// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "MANDATORY HANCESTRO DIA SHALL RECOMMEND PTM SP ROW MHC PRIDE OR III cleavage agent details SILAC MERCHANTABILITY technical replicate MIAME RIGHTS VK ... NCE ENVO HCD URI sex ALL collision energy ZFA CT FOR COULD BE DDA REQUIRES fractionation method COLUMN MAJOR SN WILL SRM IS WARRANTY NOT biosample accession number INCLUDING NOTE BRENDA TMT PMCID UBERON SHOULD JA replicate DJ FDR PATCH CPTAC PRIDE:0000659 HTML HUPO developmental stage NCBI disease TAB MC MS EBI DTT SH NT IMPLIED TO RECOMMENDED OPTIONAL XL proteomics data acquisition method PATO dissociation method biological replicate IMPORTANT REQUIRED SDRF organism part ID MT cell type disease stage MINOR USE CID CS DOID ANY LC EXPRESS TA PRM LI HF file your PEPTIDESEQ alkylation reagent MUST CLO QY PMID WARRANTIES AC MAY PSI MOD BMC characteristics EW XML II instrument CN source name_ and _assay name SWATH data file PO LIMITED ancestry category individual IAA ISA RAW DISCLAIMS PURPOSE OF mass FITNESS depletion URL PROTEOMICS PARTICULAR CELL CL INFRINGE reduction reagent TIP MS:1001251 HEREIN INFORMATION MAGE README CF organism BTO CV EFO pooled sample label fraction identifier THE BUT source name MONDO PP age exclamation PS RFC AS spiked compound STANDARDS sample INITIATIVE EM THAT IDF"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "MANDATORY HANCESTRO DIA SHALL RECOMMEND PTM SP ROW MHC PRIDE OR III cleavage agent details SILAC MERCHANTABILITY technical replicate MIAME RIGHTS VK ... NCE ENVO HCD URI sex ALL collision energy ZFA CT FOR COULD BE DDA REQUIRES fractionation method COLUMN MAJOR SN WILL SRM IS WARRANTY NOT biosample accession number INCLUDING BRENDA TMT PMCID UBERON SHOULD JA DJ FDR PATCH CPTAC PRIDE:0000659 HTML HUPO developmental stage NCBI disease TAB MC MS EBI DTT SH NT IMPLIED TO RECOMMENDED OPTIONAL XL proteomics data acquisition method PATO dissociation method biological replicate REQUIRED SDRF organism part MT cell type disease stage MINOR USE CID CS DOID ANY LC EXPRESS TA PRM LI HF PEPTIDESEQ alkylation reagent MUST CLO QY PMID WARRANTIES AC MAY PSI MOD BMC EW II instrument CN SWATH data file PO LIMITED ancestry category individual IAA ISA RAW DISCLAIMS PURPOSE OF mass FITNESS depletion URL PROTEOMICS PARTICULAR CELL CL INFRINGE reduction reagent MS:1001251 HEREIN INFORMATION MAGE README CF organism BTO CV EFO pooled sample label fraction identifier THE BUT MONDO PP age PS RFC AS spiked compound STANDARDS INITIATIVE EM THAT IDF"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "HANCESTRO MONDO:0004946 PTM synthetic peptide UBERON:0000955 MONDO:0005105 CSF CL:0000084 PATO:0000384 lib MONDO:0005180 sex ALL CL:0000182 CL:0000623 CL:0000057 MONDO:0004989 NOTE PATO:0001340 UBERON PATO:0000461 SHOULD CL:0000898 UBERON:0002107 developmental stage NCBI disease MONDO:0004975 MONDO:0005148 CL:0000787 NK CL:0000232 UBERON:0002048 CL:0000451 PATO biological replicate IMPORTANT SDRF organism part NSG ID cell type UBERON:0000178 CL:0000540 CL:0000815 CL:0000624 CL:0000236 DOID MONDO:0100096 COVID MUST UBERON:0001088 enrichment process MAY DSS UBERON:0000948 APP UBERON:0001155 PO CL:0000576 CL:0000813 MONDO:0005301 ancestry category individual CL:0000066 depletion URL UBERON:0002113 PDX disease model CL MONDO:0008383 xenograft compound TIP CL:0000233 CL:0000235 UBERON:0001969 UBERON:0002097 CML MONDO:0005575 CL:0000788 organism EFO source name MONDO age CL:0000913 UBERON:0001359 MONDO:0005138 exclamation UBERON:0000310 PATO:0000383 UBERON:0001977 CL:0000625"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "HANCESTRO MONDO:0004946 PTM synthetic peptide UBERON:0000955 MONDO:0005105 CSF CL:0000084 PATO:0000384 MONDO:0005180 sex ALL CL:0000182 CL:0000623 CL:0000057 MONDO:0004989 PATO:0001340 UBERON PATO:0000461 SHOULD CL:0000898 UBERON:0002107 developmental stage NCBI disease MONDO:0004975 MONDO:0005148 CL:0000787 NK CL:0000232 UBERON:0002048 CL:0000451 PATO biological replicate SDRF organism part NSG ID cell type UBERON:0000178 CL:0000540 CL:0000815 CL:0000624 CL:0000236 DOID MONDO:0100096 COVID MUST UBERON:0001088 enrichment process MAY DSS UBERON:0000948 APP UBERON:0001155 PO CL:0000576 CL:0000813 MONDO:0005301 ancestry category individual CL:0000066 depletion URL UBERON:0002113 PDX disease model CL MONDO:0008383 xenograft compound CL:0000233 CL:0000235 UBERON:0001969 UBERON:0002097 CML MONDO:0005575 CL:0000788 organism EFO source name MONDO age CL:0000913 UBERON:0001359 MONDO:0005138 UBERON:0000310 PATO:0000383 UBERON:0001977 CL:0000625"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C14169 HANCESTRO TNM NCIT:C18206 NCIT:C65106 ethnicity body mass index III NCIT:C15329 NCIT:C53555 NCIT:C15313 Ann Arbor stage pre-existing condition sex MONDO:0011122 NCIT:C81327 HANCESTRO:0005 MONDO:0004995 NCIT:C28076 NCIT:C53556 secondary condition time post treatment NCIT:C28079 NOTE NCIT:C15445 NCIT:C65107 NCIT:C14167 NCIT:C62723 disease NCIT:C53554 NCIT:C18058 MONDO:0005148 NCIT:C16358 MONDO:0002050 NCIT:C81328 diet NCIT:C15632 HANCESTRO:0010 IV NCIT:C65108 IMPORTANT SDRF dose organism part ID PREFERRED menopausal status GDPR prior treatment treatment status NCIT:C4870 disease stage CHEBI:6801 HANCESTRO:0006 PR alcohol consumption MONDO:0004979 Dukes stage UO TNM staging NCIT:C28078 pregnancy status NCIT ER CHEBI:27899 PD MONDO:0005044 HANCESTRO:0009 NCI NCIT:C27966 NCIT:C28054 height NCIT:C28077 II NCIT:C14174 treatment response smoking status ancestry category individual BMI CHEBI:28748 NCIT:C27971 CHEBI:41774 treatment sampling time point NCIT:C14168 HIPAA NCIT:C71732 tumor grade compound AJCC gestational age ACE NCIT:C18213 NCIT:C27970 NCIT:C53553 organism EFO MONDO:0005300 medication history MONDO age NCIT:C68804 exclamation breast cancer subtype weight NCIT:C15262"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C14169 HANCESTRO TNM NCIT:C18206 NCIT:C65106 ethnicity body mass index III NCIT:C15329 NCIT:C53555 NCIT:C15313 Ann Arbor stage pre-existing condition sex MONDO:0011122 NCIT:C81327 HANCESTRO:0005 MONDO:0004995 NCIT:C28076 NCIT:C53556 secondary condition time post treatment NCIT:C28079 NCIT:C15445 NCIT:C65107 NCIT:C14167 NCIT:C62723 disease NCIT:C53554 NCIT:C18058 MONDO:0005148 NCIT:C16358 MONDO:0002050 NCIT:C81328 diet NCIT:C15632 HANCESTRO:0010 IV NCIT:C65108 SDRF dose organism part ID PREFERRED menopausal status GDPR prior treatment treatment status NCIT:C4870 disease stage CHEBI:6801 HANCESTRO:0006 PR alcohol consumption MONDO:0004979 Dukes stage UO TNM staging NCIT:C28078 pregnancy status NCIT ER CHEBI:27899 PD MONDO:0005044 HANCESTRO:0009 NCI NCIT:C27966 NCIT:C28054 height NCIT:C28077 II NCIT:C14174 treatment response smoking status ancestry category individual BMI CHEBI:28748 NCIT:C27971 CHEBI:41774 treatment sampling time point NCIT:C14168 HIPAA NCIT:C71732 tumor grade compound AJCC gestational age ACE NCIT:C18213 NCIT:C27970 NCIT:C53553 organism EFO MONDO:0005300 medication history MONDO age NCIT:C68804 breast cancer subtype weight NCIT:C15262"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "RAW DIA TOF MGF NOTE MS2 analyzer type TMT CS UNIMOD:21 URL SHOULD MS:1001306 modification parameters MRM PRIDE cleavage agent details SILAC RPPA UNIMOD technical replicate scan window lower limit precursor mass tolerance TA PRM proteomexchange accession number scan window upper limit TIP HF MS:1001251 MS1 scan range MS MUST SCIEX UNIMOD:4 fraction KR ST AC MS:1001309 ELISA NT PSI RECOMMENDED MOD CF URI UNIMOD:737 label fraction identifier LTQ XL TS PP MS:1001917 proteomics data acquisition method exclamation instrument DDA MSD IMPORTANT UNIMOD:1 MM REQUIRED SDRF MT MS:1001303 fragment mass tolerance file uri ID MS:1001313 data file sample UNIMOD:35 SRM FTP PRIDE:0000663"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "RAW DIA TOF MGF MS2 analyzer type TMT CS UNIMOD:21 URL SHOULD MS:1001306 modification parameters MRM PRIDE cleavage agent details SILAC RPPA UNIMOD technical replicate scan window lower limit precursor mass tolerance TA PRM proteomexchange accession number scan window upper limit HF MS:1001251 MS1 scan range MS MUST SCIEX UNIMOD:4 KR ST AC MS:1001309 ELISA NT PSI RECOMMENDED MOD CF URI UNIMOD:737 label fraction identifier LTQ XL TS PP MS:1001917 proteomics data acquisition method instrument DDA MSD UNIMOD:1 MM MS:1001303 REQUIRED SDRF MT fragment mass tolerance file uri ID MS:1001313 data file UNIMOD:35 SRM FTP PRIDE:0000663"
  },
  {
    "title": "SDRF-Proteomics: Immunopeptidomics Template",
    "content": "SDRF-Proteomics: Immunopeptidomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating immunopeptidomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with immunopeptidomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nImmunopeptidomics is a specialized field of proteomics that focuses on the identification and characterization of peptides presented by major histocompatibility complex (MHC) molecules on the cell surface. These MHC-bound peptides, collectively known as the immunopeptidome, play a critical role in immune recognition and are essential for understanding:\n\n- T-cell mediated immune responses\n- Antigen presentation mechanisms\n- Tumor-associated antigens for cancer immunotherapy\n- Vaccine development and infectious disease research\n\nThis template defines the additional metadata requirements for properly annotating immunopeptidomics datasets in SDRF-Proteomics format, enabling better data sharing, reproducibility, and integration with immunological databases.\n\nMotivation\n\nImmunopeptidomics experiments have unique characteristics that distinguish them from standard proteomics workflows:\n\n1. Specialized sample preparation: MHC-peptide complexes require specific enrichment methods (e.g., immunoaffinity purification using anti-MHC antibodies)\n2. Short peptide focus: Unlike tryptic digests, immunopeptides are naturally processed and typically 8-15 amino acids for MHC class I or 13-25 amino acids for MHC class II\n3. HLA polymorphism: Human samples require HLA typing information to interpret peptide binding motifs\n4. No enzymatic digestion: Peptides are naturally cleaved by the immunoproteasome and other cellular proteases\n\nThese unique aspects require additional metadata beyond the standard SDRF-Proteomics fields to enable proper ",
    "url": "./templates/immunopeptidomics.html",
    "section": "Immunopeptidomics Template",
    "keywords": "individual NOT tissue mass biosample accession number TFA IEDB antibody used MHC immunopeptidome enrichment method MRO PRIDE elution conditions cell line cleavage agent details IMGT HTML VO cells disease SSO JY HF file your HLA typing method NGS immunopeptidome label organism RECOMMENDED CV EFO fraction identifier HLA AW MHC binding prediction II biological replicate instrument exclamation REQUIRED SDRF cell number PCR data file DR MHC class HLA typing"
  },
  {
    "title": "SDRF-Proteomics: Immunopeptidomics Template",
    "content": "SDRF-Proteomics: Immunopeptidomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating immunopeptidomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with immunopeptidomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nImmunopeptidomics is a specialized field of proteomics that focuses on the identification and characterization of peptides presented by major histocompatibility complex (MHC) molecules on the cell surface. These MHC-bound peptides, collectively known as the immunopeptidome, play a critical role in immune recognition and are essential for understanding:\n\n- T-cell mediated immune responses\n- Antigen presentation mechanisms\n- Tumor-associated antigens for cancer immunotherapy\n- Vaccine development and infectious disease research\n\nThis template defines the additional metadata requirements for properly annotating immunopeptidomics datasets in SDRF-Proteomics format, enabling better data sharing, reproducibility, and integration with immunological databases.\n\nMotivation\n\nImmunopeptidomics experiments have unique characteristics that distinguish them from standard proteomics workflows:\n\n1. Specialized sample preparation: MHC-peptide complexes require specific enrichment methods (e.g., immunoaffinity purification using anti-MHC antibodies)\n2. Short peptide focus: Unlike tryptic digests, immunopeptides are naturally processed and typically 8-15 amino acids for MHC class I or 13-25 amino acids for MHC class II\n3. HLA polymorphism: Human samples require HLA typing information to interpret peptide binding motifs\n4. No enzymatic digestion: Peptides are naturally cleaved by the immunoproteasome and other cellular proteases\n\nThese unique aspects require additional metadata beyond the standard SDRF-Proteomics fields to enable proper ",
    "url": "./templates/immunopeptidomics.html#sdrf-proteomics-immunopeptidomics-template",
    "section": "Immunopeptidomics Template",
    "keywords": "individual NOT tissue mass biosample accession number TFA IEDB antibody used MHC immunopeptidome enrichment method MRO PRIDE elution conditions cell line cleavage agent details IMGT HTML VO disease SSO JY HF HLA typing method NGS label organism RECOMMENDED CV EFO fraction identifier HLA AW MHC binding prediction II biological replicate instrument REQUIRED SDRF cell number PCR data file DR MHC class HLA typing"
  },
  {
    "title": "SDRF-Proteomics: Affinity Proteomics Template",
    "content": "SDRF-Proteomics: Affinity Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating affinity-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with affinity proteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nAffinity proteomics encompasses experimental approaches that use affinity-based capture methods to study specific protein subsets or interactions. Unlike mass spectrometry-based proteomics, these methods typically use antibodies, aptamers, or other affinity reagents to detect and quantify proteins. Major platforms include:\n\n- Proximity Extension Assay (PEA): Olink platform using antibody pairs and DNA barcoding\n- Aptamer-based assays: SomaScan platform using modified aptamers (SOMAmer reagents)\n- Antibody arrays: Various bead-based and planar array platforms\n- Immunoaffinity-MS: Hybrid approaches combining affinity capture with MS detection\n\nThis template defines metadata requirements for annotating these diverse affinity-based proteomics experiments, enabling data integration across platforms and with mass spectrometry data.\n\nMotivation\n\nAffinity proteomics experiments have characteristics that differ significantly from mass spectrometry proteomics:\n\n1. Pre-defined protein panels: Target proteins are determined by the reagent panel, not by detection\n2. No mass spectrometry (typically): Detection is often via sequencing, fluorescence, or electrochemiluminescence\n3. High throughput: Many samples can be processed in parallel\n4. Different quantification scales: Relative units (NPX, RFU) rather than intensity or spectral counts\n5. Platform-specific considerations: Each technology has unique metadata requirements\n\nThese aspects require specific metadata to enable proper data interpretation and cross-platform co",
    "url": "./templates/affinity-proteomics.html",
    "section": "Affinity Proteomics Template",
    "keywords": "MFI biosample accession number HA NOTE capture antibody antibody source ARRAY olink panel panel composition somascan platform EDTA ELLA ONE MRM quantification unit LOD olink lot number RPPA panel version HTML CSV disease CSF file your SISCAPA QC warning MS GFP MUST bead type affinity reagent QC detection sensitivity IP affinity method sample volume DNA organism RECOMMENDED CV sample matrix dilution factor JM HT ADAT NHS PEA RFU II target protein class MSD panel name IMPORTANT somascan menu exclamation REQUIRED SDRF FLAG NPX normalization standard curve data file enrichment method NPX normalization method assay platform MULTI sample type olink platform detection method"
  },
  {
    "title": "SDRF-Proteomics: Affinity Proteomics Template",
    "content": "SDRF-Proteomics: Affinity Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating affinity-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with affinity proteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nAffinity proteomics encompasses experimental approaches that use affinity-based capture methods to study specific protein subsets or interactions. Unlike mass spectrometry-based proteomics, these methods typically use antibodies, aptamers, or other affinity reagents to detect and quantify proteins. Major platforms include:\n\n- Proximity Extension Assay (PEA): Olink platform using antibody pairs and DNA barcoding\n- Aptamer-based assays: SomaScan platform using modified aptamers (SOMAmer reagents)\n- Antibody arrays: Various bead-based and planar array platforms\n- Immunoaffinity-MS: Hybrid approaches combining affinity capture with MS detection\n\nThis template defines metadata requirements for annotating these diverse affinity-based proteomics experiments, enabling data integration across platforms and with mass spectrometry data.\n\nMotivation\n\nAffinity proteomics experiments have characteristics that differ significantly from mass spectrometry proteomics:\n\n1. Pre-defined protein panels: Target proteins are determined by the reagent panel, not by detection\n2. No mass spectrometry (typically): Detection is often via sequencing, fluorescence, or electrochemiluminescence\n3. High throughput: Many samples can be processed in parallel\n4. Different quantification scales: Relative units (NPX, RFU) rather than intensity or spectral counts\n5. Platform-specific considerations: Each technology has unique metadata requirements\n\nThese aspects require specific metadata to enable proper data interpretation and cross-platform co",
    "url": "./templates/affinity-proteomics.html#sdrf-proteomics-affinity-proteomics-template",
    "section": "Affinity Proteomics Template",
    "keywords": "MFI biosample accession number HA capture antibody antibody source ARRAY olink panel panel composition somascan platform EDTA ELLA ONE MRM quantification unit LOD olink lot number RPPA panel version HTML CSV disease CSF SISCAPA QC warning MS GFP MUST bead type affinity reagent QC detection sensitivity IP affinity method sample volume DNA organism RECOMMENDED CV sample matrix dilution factor JM HT ADAT NHS PEA RFU II target protein class MSD panel name somascan menu REQUIRED SDRF FLAG NPX normalization standard curve data file enrichment method NPX normalization method assay platform MULTI sample type olink platform detection method"
  },
  {
    "title": "SDRF-Proteomics: Single Cell Proteomics Template",
    "content": "SDRF-Proteomics: Single Cell Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating single cell proteomics (SCP) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with single-cell-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSingle cell proteomics (SCP) aims to characterize the proteome at the level of individual cells, providing insights into cellular heterogeneity that are not accessible through bulk proteomics methods. SCP enables the study of:\n\n- Cell-to-cell variability within populations\n- Rare cell populations and their unique protein signatures\n- Cellular state transitions and differentiation trajectories\n- Protein expression dynamics at single-cell resolution\n\nThis template defines the additional metadata requirements for properly annotating single cell proteomics datasets in SDRF-Proteomics format, supporting data integration, reproducibility, and cross-study comparisons.\n\nMotivation\n\nSingle cell proteomics experiments have unique characteristics that distinguish them from bulk proteomics:\n\n1. Cell isolation methods: Individual cells must be isolated using techniques like FACS, micromanipulation, or microfluidic platforms\n2. Ultra-low sample input: Working with picogram to low nanogram amounts of protein requires specialized sample preparation\n3. Carrier proteome strategies: Many SCP methods use carrier channels or carrier proteome to boost signal\n4. Cell-level metadata: Each cell requires individual annotation including cell identifiers and potentially spatial coordinates\n5. High-throughput multiplexing: Methods like SCoPE-MS and similar use TMT labeling to multiplex many cells per run\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nSingle cell pro",
    "url": "./templates/single-cell.html",
    "section": "Single Cell Template",
    "keywords": "cell viability section NOTE MS2 identification rate TMT cells per well run FACS spatial coordinates well carrier channel PRIDE cell collection method SCP CL carrier proteome cleavage agent details HTML RT disease MS:1001251 reference channel file your MS GFP MUST proteins identified LCM RNA AC cell cycle phase NT label organism RECOMMENDED CV EFO fraction identifier cell EDAM missing value percentage peptides identified exclamation biological replicate instrument sorting marker REQUIRED SDRF PI cell diameter ATAC cell identifier data file single cell isolation method cell type"
  },
  {
    "title": "SDRF-Proteomics: Single Cell Proteomics Template",
    "content": "SDRF-Proteomics: Single Cell Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating single cell proteomics (SCP) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with single-cell-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSingle cell proteomics (SCP) aims to characterize the proteome at the level of individual cells, providing insights into cellular heterogeneity that are not accessible through bulk proteomics methods. SCP enables the study of:\n\n- Cell-to-cell variability within populations\n- Rare cell populations and their unique protein signatures\n- Cellular state transitions and differentiation trajectories\n- Protein expression dynamics at single-cell resolution\n\nThis template defines the additional metadata requirements for properly annotating single cell proteomics datasets in SDRF-Proteomics format, supporting data integration, reproducibility, and cross-study comparisons.\n\nMotivation\n\nSingle cell proteomics experiments have unique characteristics that distinguish them from bulk proteomics:\n\n1. Cell isolation methods: Individual cells must be isolated using techniques like FACS, micromanipulation, or microfluidic platforms\n2. Ultra-low sample input: Working with picogram to low nanogram amounts of protein requires specialized sample preparation\n3. Carrier proteome strategies: Many SCP methods use carrier channels or carrier proteome to boost signal\n4. Cell-level metadata: Each cell requires individual annotation including cell identifiers and potentially spatial coordinates\n5. High-throughput multiplexing: Methods like SCoPE-MS and similar use TMT labeling to multiplex many cells per run\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nSingle cell pro",
    "url": "./templates/single-cell.html#sdrf-proteomics-single-cell-proteomics-template",
    "section": "Single Cell Template",
    "keywords": "cell viability MS2 identification rate TMT cells per well FACS spatial coordinates carrier channel PRIDE cell collection method SCP CL carrier proteome cleavage agent details HTML RT disease MS:1001251 reference channel MS GFP MUST proteins identified LCM RNA AC cell cycle phase NT label organism RECOMMENDED CV EFO fraction identifier EDAM missing value percentage peptides identified biological replicate instrument sorting marker REQUIRED SDRF PI cell diameter ATAC cell identifier data file single cell isolation method cell type"
  },
  {
    "title": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template",
    "content": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating crosslinking mass spectrometry (XL-MS) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with crosslinking-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCrosslinking mass spectrometry (XL-MS) is a powerful structural proteomics technique that uses chemical reagents to covalently link amino acid residues in close spatial proximity. This approach provides valuable information for:\n\n- Protein structure determination and validation\n- Protein-protein interaction mapping\n- Characterization of protein complexes\n- Integrative structural biology pipelines\n- In vivo and in situ structural studies\n\nThis template defines the additional metadata requirements for properly annotating crosslinking mass spectrometry datasets in SDRF-Proteomics format, enabling proper interpretation of structural constraints and data reproducibility.\n\nMotivation\n\nCrosslinking mass spectrometry experiments have unique characteristics that distinguish them from standard proteomics:\n\n1. Crosslinking chemistry: Various reagents with different specificities and spacer arm lengths are used\n2. Distance constraints: The crosslinker spacer arm defines the maximum distance between linked residues\n3. Reaction conditions: Crosslinking efficiency depends on concentration, time, and temperature\n4. Specialized data analysis: XL-MS requires dedicated search engines that identify crosslinked peptide pairs\n5. Enrichment strategies: Crosslinked peptides are often enriched using specific strategies (SEC, SCX, affinity)\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Structural Biology\n\nCrosslinking mass spectrometry data is typically integrate",
    "url": "./templates/crosslinking.html",
    "section": "Crosslinking Template",
    "keywords": "FAIMS crosslink distance cleavable crosslinker CID crosslinking target crosslink type label crosslinking reagent HADDOCK cell type IMP SDA crosslink search engine FDR crosslink FDR cleavage agent details crosslinking reaction time HTML EDC disease MS:1001251 FJ crosslinker spacer arm length crosslinking context cleavage reporter ions MS PIR crosslinks identified file your fragmentation method for cleavage DSSO MS:1002494 crosslinker concentration AC crosslink target residues NT HCD PSI RECOMMENDED PDB CV DSS RP organism TG cell permeability XL exclamation quenching reagent NHS SEC XLMOD:02001 SA SCX DSBU biological replicate fraction identifier crosslinker to protein ratio instrument REQUIRED SDRF crosslink enrichment method XLMOD xl data file prep EM crosslinking temperature ETD"
  },
  {
    "title": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template",
    "content": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating crosslinking mass spectrometry (XL-MS) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with crosslinking-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCrosslinking mass spectrometry (XL-MS) is a powerful structural proteomics technique that uses chemical reagents to covalently link amino acid residues in close spatial proximity. This approach provides valuable information for:\n\n- Protein structure determination and validation\n- Protein-protein interaction mapping\n- Characterization of protein complexes\n- Integrative structural biology pipelines\n- In vivo and in situ structural studies\n\nThis template defines the additional metadata requirements for properly annotating crosslinking mass spectrometry datasets in SDRF-Proteomics format, enabling proper interpretation of structural constraints and data reproducibility.\n\nMotivation\n\nCrosslinking mass spectrometry experiments have unique characteristics that distinguish them from standard proteomics:\n\n1. Crosslinking chemistry: Various reagents with different specificities and spacer arm lengths are used\n2. Distance constraints: The crosslinker spacer arm defines the maximum distance between linked residues\n3. Reaction conditions: Crosslinking efficiency depends on concentration, time, and temperature\n4. Specialized data analysis: XL-MS requires dedicated search engines that identify crosslinked peptide pairs\n5. Enrichment strategies: Crosslinked peptides are often enriched using specific strategies (SEC, SCX, affinity)\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Structural Biology\n\nCrosslinking mass spectrometry data is typically integrate",
    "url": "./templates/crosslinking.html#sdrf-proteomics-crosslinking-mass-spectrometry-template",
    "section": "Crosslinking Template",
    "keywords": "FAIMS crosslink distance cleavable crosslinker CID crosslinking target crosslink type label crosslinking reagent HADDOCK cell type IMP SDA crosslink search engine FDR crosslink FDR cleavage agent details crosslinking reaction time HTML EDC disease MS:1001251 FJ crosslinker spacer arm length crosslinking context cleavage reporter ions MS PIR crosslinks identified fragmentation method for cleavage DSSO MS:1002494 crosslinker concentration AC crosslink target residues NT HCD PSI RECOMMENDED PDB CV DSS RP organism TG cell permeability XL quenching reagent NHS SEC XLMOD:02001 SA SCX DSBU biological replicate fraction identifier crosslinker to protein ratio instrument REQUIRED SDRF crosslink enrichment method XLMOD data file EM crosslinking temperature ETD"
  },
  {
    "title": "SDRF-Proteomics: Metaproteomics Template",
    "content": "SDRF-Proteomics: Metaproteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating metaproteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with metaproteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nMetaproteomics is the study of proteins expressed by microbial communities, providing insights into the functional potential and activity of microbiomes. Unlike single-organism proteomics, metaproteomics analyzes complex samples containing proteins from many different organisms simultaneously. Key applications include:\n\n- Gut microbiome functional characterization\n- Environmental microbiology (soil, ocean, wastewater)\n- Host-microbiome interactions\n- Pathogen-host dynamics\n- Industrial biotechnology (bioreactors, fermentation)\n\nThis template defines the additional metadata requirements for properly annotating metaproteomics datasets in SDRF-Proteomics format, addressing the unique challenges of multi-organism samples.\n\nMotivation\n\nMetaproteomics experiments have unique characteristics that distinguish them from single-organism proteomics:\n\n1. Multi-organism samples: Samples contain proteins from many different species/taxa\n2. Complex sample matrices: Environmental, fecal, or other challenging sample types\n3. Database construction challenges: Sequence databases may be constructed from metagenomics data\n4. Taxonomic attribution: Peptides may be assigned to specific taxa or remain ambiguous\n5. Environmental context: Geographic, temporal, and environmental conditions are critical metadata\n6. Host-microbe separation: For host-associated microbiomes, host proteins may need to be distinguished\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nMetaproteomics data is ",
    "url": "./templates/metaproteomics.html",
    "section": "Metaproteomics Template",
    "keywords": "microbiome source GAZ sed metagenome accession NOTE altitude mock community composition water body type host disease body site soil horizon salinity geographic location cleavage agent details ATCC host contamination HTML antibiotic treatment host organism environmental sample type pH contaminant database NCBI biomass estimation vegetation HF MS:1001251 file your sample storage USA PL GAZ:00002459 ENVO GTDB AC NT label PSU RECOMMENDED CV EFO MSA depth host age land use ISO organism MONDO soil type database search strategy exclamation biological replicate instrument UHGG fraction identifier collection date REQUIRED SDRF dissolved oxygen ITS expected organism list data file farm sample collection method sampling depth zone host diet mock community temperature chlorophyll"
  },
  {
    "title": "SDRF-Proteomics: Metaproteomics Template",
    "content": "SDRF-Proteomics: Metaproteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating metaproteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with metaproteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nMetaproteomics is the study of proteins expressed by microbial communities, providing insights into the functional potential and activity of microbiomes. Unlike single-organism proteomics, metaproteomics analyzes complex samples containing proteins from many different organisms simultaneously. Key applications include:\n\n- Gut microbiome functional characterization\n- Environmental microbiology (soil, ocean, wastewater)\n- Host-microbiome interactions\n- Pathogen-host dynamics\n- Industrial biotechnology (bioreactors, fermentation)\n\nThis template defines the additional metadata requirements for properly annotating metaproteomics datasets in SDRF-Proteomics format, addressing the unique challenges of multi-organism samples.\n\nMotivation\n\nMetaproteomics experiments have unique characteristics that distinguish them from single-organism proteomics:\n\n1. Multi-organism samples: Samples contain proteins from many different species/taxa\n2. Complex sample matrices: Environmental, fecal, or other challenging sample types\n3. Database construction challenges: Sequence databases may be constructed from metagenomics data\n4. Taxonomic attribution: Peptides may be assigned to specific taxa or remain ambiguous\n5. Environmental context: Geographic, temporal, and environmental conditions are critical metadata\n6. Host-microbe separation: For host-associated microbiomes, host proteins may need to be distinguished\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nMetaproteomics data is ",
    "url": "./templates/metaproteomics.html#sdrf-proteomics-metaproteomics-template",
    "section": "Metaproteomics Template",
    "keywords": "microbiome source GAZ metagenome accession altitude mock community composition water body type host disease body site soil horizon salinity geographic location cleavage agent details ATCC host contamination HTML antibiotic treatment host organism environmental sample type pH contaminant database NCBI biomass estimation vegetation HF MS:1001251 sample storage USA PL GAZ:00002459 ENVO GTDB AC NT label PSU RECOMMENDED CV EFO MSA depth host age land use ISO organism MONDO soil type database search strategy biological replicate instrument UHGG fraction identifier collection date REQUIRED SDRF dissolved oxygen ITS expected organism list data file sample collection method sampling depth zone host diet mock community temperature chlorophyll"
  },
  {
    "title": "SDRF-Proteomics: Cell Line Template",
    "content": "SDRF-Proteomics: Cell Line Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating cell line-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with cell line-specific metadata fields and resources.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCell lines are extensively used in proteomics research, both for biological studies and for technology/method development. Cell lines present unique annotation challenges because:\n\n- They have well-defined characteristics that can be retrieved from databases\n- Metadata like sex, age, and disease refer to the original donor, not the cell line passage\n- Multiple databases and ontologies exist for cell line identification\n- Cell lines may be misidentified, contaminated, or have undergone genetic drift\n\nThis template defines standardized approaches for annotating cell line experiments, including the use of Cellosaurus as the primary resource for cell line identification and metadata.\n\nMotivation\n\nCell line annotation in proteomics datasets has historically been inconsistent:\n\n1. Multiple naming conventions: HeLa, HELA, He-La may all refer to the same cell line\n2. Outdated ontologies: The Cell Line Ontology (CLO) has not been actively maintained\n3. Missing metadata: Key information about donor characteristics is often omitted\n4. No standard identifiers: Lack of consistent accession numbers for cell lines\n\nThis template addresses these issues by:\n\n- Recommending Cellosaurus as the primary cell line resource\n- Providing a curated database of cell line metadata for SDRF annotation\n- Defining which metadata fields should be populated from databases vs. experiment-specific annotation\n\nCellosaurus: The Primary Cell Line Resource\n\nCellosaurus is a comprehensive knowledge resource on cell lines maintained by the SIB Swiss I",
    "url": "./templates/cell-lines.html",
    "section": "Cell Lines Template",
    "keywords": "CLO:0003684 NOT SNP MB MDA culture conditions cell line notes EFO:0001185 BRENDA treatment cell line modifications RECOMMEND authentication method STR SHOULD mycoplasma status RPMI HELA ICLAC CRISPR cell line ATCC HTML DMEM developmental stage treat disease compound SIB sampling site file your GFP ctrl bto cell line CLO ECACC passage number cellosaurus accession sex organism RECOMMENDED BTO BTO:0000567 EFO age DSMZ ancestry category cellosaurus name material type exclamation XXXX FBS biological replicate IMPORTANT REQUIRED SDRF organism part cell line synonyms ID cell line source data file RECOMMENDS OS cell type"
  },
  {
    "title": "SDRF-Proteomics: Cell Line Template",
    "content": "SDRF-Proteomics: Cell Line Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating cell line-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with cell line-specific metadata fields and resources.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCell lines are extensively used in proteomics research, both for biological studies and for technology/method development. Cell lines present unique annotation challenges because:\n\n- They have well-defined characteristics that can be retrieved from databases\n- Metadata like sex, age, and disease refer to the original donor, not the cell line passage\n- Multiple databases and ontologies exist for cell line identification\n- Cell lines may be misidentified, contaminated, or have undergone genetic drift\n\nThis template defines standardized approaches for annotating cell line experiments, including the use of Cellosaurus as the primary resource for cell line identification and metadata.\n\nMotivation\n\nCell line annotation in proteomics datasets has historically been inconsistent:\n\n1. Multiple naming conventions: HeLa, HELA, He-La may all refer to the same cell line\n2. Outdated ontologies: The Cell Line Ontology (CLO) has not been actively maintained\n3. Missing metadata: Key information about donor characteristics is often omitted\n4. No standard identifiers: Lack of consistent accession numbers for cell lines\n\nThis template addresses these issues by:\n\n- Recommending Cellosaurus as the primary cell line resource\n- Providing a curated database of cell line metadata for SDRF annotation\n- Defining which metadata fields should be populated from databases vs. experiment-specific annotation\n\nCellosaurus: The Primary Cell Line Resource\n\nCellosaurus is a comprehensive knowledge resource on cell lines maintained by the SIB Swiss I",
    "url": "./templates/cell-lines.html#sdrf-proteomics-cell-line-template",
    "section": "Cell Lines Template",
    "keywords": "CLO:0003684 NOT SNP MB MDA culture conditions cell line notes EFO:0001185 BRENDA treatment cell line modifications RECOMMEND authentication method STR SHOULD mycoplasma status RPMI HELA ICLAC CRISPR cell line ATCC HTML DMEM developmental stage disease compound SIB sampling site GFP bto cell line CLO ECACC passage number cellosaurus accession sex organism RECOMMENDED BTO BTO:0000567 EFO age CVCLXXXX DSMZ ancestry category cellosaurus name material type XXXX FBS biological replicate REQUIRED SDRF organism part cell line synonyms ID cell line source data file RECOMMENDS OS cell type"
  }
];
